Click to Share

Filter News
Show All Results
News By Country
News By Tag
Gpcr Remove

July 2016

Public Company News

Business Press Releases

Gpcr Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Cambridge Healthtech Institute
Top scientists from pharma and biotech to deliver new data and case studies for using structure and rational design to accelerate discovery
By SMi Group
SMi are delighted to announce that Roche will now be speaking at the 13th annual conference on Advances and Progress in Drug Design taking place next February in London.
By Cambridge Healthtech Institute
Presentation download from the Structure-Based Drug Design 2012 conference organized by Cambridge Healthtech Institute & Bio-IT World
By Cambridge Healthtech Institute
Event Focus will be Predicting Biological and Kinetic Profiles from Structure
By Cambridge Healthtech Institute
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities
By Visiongain Ltd.
GPCR & Kinase Targets Advances in drug discovery from molecular to clinical 14th - 15th April 2011, Thistle City Barbican, London, UK
By visiongain
Comprising more than 60% of all therapeutic targets, G-protein coupled receptor and kinase targets are arguably the most exciting proteins in pharmacology today. Find out more by attending this key event
By Cambridge Healthech Institute
Cambridge Healthtech Institute, a premier information provider for the life sciences industry, will host its Eighth International Discovery on Target meeting on November 2-4, 2010 in Boston, Massachusetts.
By Fast Market Research
New Pharmaceuticals market report from Business Insights: "The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion"
By Ekta Ahuja
Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.
By Andrey Grischenko
Otava releases two GPCR-related focused libraries. The libraries have been designed with QSAR using training set. These libraries are proposed for screening in GPCR-associated research and drug development.
By Sally Wang
GenScript's Ready-to-UseTM frozen cell series is designed to expedite cellular assays.

Page updated every 10 minutes

Like PRLog?
Click to Share